Publications by authors named "Elodie Plan"

Claim this Profile
I
Item Response Modeling and Artificial Neural Network for Differentiation of Parkinson's Patients and Subjects Without Evidence of Dopaminergic Deficit.
Leticia Arrington, Sven C van Dijkman, Elodie L Plan, Mats O Karlsson

CPT Pharmacometrics Syst Pharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Drug-Drug Interaction and Food Effect for BCS Class 2 Compound BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma Antagonist, Bevurogant) Using a Physiology-Based Pharmacokinetics Modeling (PBPK) Approach with Semi-Mechanistic Absorption.
Tobias Kanacher, Erik Sjögren, Julia Korell, Elodie L Plan, Jose David Gómez-Mantilla

Pharmaceutics· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tutorial on pharmacometric Markov models.
Qing Xi Ooi, Elodie Plan, Martin Bergstrand

CPT Pharmacometrics Syst Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Model-Based Evaluation of Noninvasive Biomarkers to Reflect Histological Nonalcoholic Fatty Liver Disease Scores.
Iris K Minichmayr, Elodie L Plan, Benjamin Weber, Sebastian Ueckert

Pharm Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Comparisons of Progressive Supranuclear Palsy Rating Scale Versions Using Item Response Theory.
Mohamed Gewily, Elodie L Plan, Elham Yousefi, Franz König, Martin Posch

Mov Disord· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity dynamics and covariate effects after satralizumab administration predicted with a hidden Markov model.
Rory Leisegang, Hanna E Silber Baumann, Siân Lennon-Chrimes, Hajime Ito, Kazuhiro Miya, Elodie L Plan

CPT Pharmacometrics Syst Pharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Training the next generation of pharmacometric modelers: a multisector perspective.
Peter L Bonate, Jeffrey S Barrett, Sihem Ait-Oudhia, Richard Brundage, Brian Corrigan, Elodie L Plan

J Pharmacokinet Pharmacodyn· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Training the next generation of pharmacometric modelers: a multisector perspective.
Peter L Bonate, Jeffrey S Barrett, Sihem Ait-Oudhia, Richard Brundage, Brian Corrigan, Elodie L Plan

J Pharmacokinet Pharmacodyn· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of anti-drug antibody dynamics using a bivariate mixed hidden-markov model by nonlinear-mixed effects approach.
Ari Brekkan, Rocío Lledo-Garcia, Brigitte Lacroix, Siv Jönsson, Mats O Karlsson, Elodie L Plan

J Pharmacokinet Pharmacodyn· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score.
Anita Moein, Jurgen Langenhorst, Elodie L Plan, Jin Y Jin, Matts Kågedal

Clin Transl Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint longitudinal model-based meta-analysis of FEV and exacerbation rate in randomized COPD trials.
Carolina Llanos-Paez, Claire Ambery, Shuying Yang, Misba Beerahee, Elodie L Plan

J Pharmacokinet Pharmacodyn· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Confidence in a Confirmatory Stage by Application of Item-Based Pharmacometrics Model: Illustration with a Phase III Active Comparator-Controlled Trial in COPD Patients.
Carolina Llanos-Paez, Claire Ambery, Shuying Yang, Misba Beerahee, Elodie L Plan

Pharm Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Decision-Making Confidence Using Item-Based Pharmacometric Model: Illustration with a Phase II Placebo-Controlled Trial.
Carolina Llanos-Paez, Claire Ambery, Shuying Yang, Maggie Tabberer, Misba Beerahee, Elodie L Plan

AAPS J· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting placebo and drug effects on Parkinson's disease symptoms by longitudinal item-score models.
Chao Chen, Siv Jönsson, Shuying Yang, Elodie L Plan, Mats O Karlsson

CPT Pharmacometrics Syst Pharmacol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity of Pegfilgrastim Pharmacokinetic and Pharmacodynamic Parameters to Product Differences in Similarity Studies.
Ari Brekkan, Luis Lopez-Lazaro, Elodie L Plan, Joakim Nyberg, Suresh Kankanwadi

AAPS J· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Item Response Model Adaptation for Analyzing Data from Different Versions of Parkinson's Disease Rating Scales.
Gopichand Gottipati, Alienor C Berges, Shuying Yang, Chao Chen, Mats O Karlsson, Elodie L Plan

Pharm Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Method for Analysing Frequent Observations from Questionnaires in Order to Model Patient-Reported Outcomes: Application to EXACT® Daily Diary Data from COPD Patients.
Eva Germovsek, Claire Ambery, Shuying Yang, Misba Beerahee, Mats O Karlsson, Elodie L Plan

AAPS J· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim.
Ari Brekkan, Luis Lopez-Lazaro, Gunnar Yngman, Elodie L Plan, Chayan Acharya

AAPS J· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling a Composite Score in Parkinson's Disease Using Item Response Theory.
Gopichand Gottipati, Mats O Karlsson, Elodie L Plan

AAPS J· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with Schizophrenia.
Mats O Magnusson, Mahesh N Samtani, Elodie L Plan, E Niclas Jonsson, Stefaan Rossenu

Clin Pharmacokinet· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing and Switching Strategies for Paliperidone Palmitate 3-Month Formulation in Patients with Schizophrenia Based on Population Pharmacokinetic Modeling and Simulation, and Clinical Trial Data.
Mats O Magnusson, Mahesh N Samtani, Elodie L Plan, E Niclas Jonsson, Stefaan Rossenu

CNS Drugs· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approaches for modeling within subject variability in pharmacometric count data analysis: dynamic inter-occasion variability and stochastic differential equations.
Chenhui Deng, Elodie L Plan, Mats O Karlsson

J Pharmacokinet Pharmacodyn· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved utilization of ADAS-cog assessment data through item response theory based pharmacometric modeling.
Sebastian Ueckert, Elodie L Plan, Kaori Ito, Mats O Karlsson, Brian Corrigan

Pharm Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of bias, precision, robustness and runtime for estimation methods in NONMEM 7.
Åsa M Johansson, Sebastian Ueckert, Elodie L Plan, Andrew C Hooker, Mats O Karlsson

J Pharmacokinet Pharmacodyn· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance comparison of various maximum likelihood nonlinear mixed-effects estimation methods for dose-response models.
Elodie L Plan, Alan Maloney, France Mentré, Mats O Karlsson, Julie Bertrand

AAPS J· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis